ArticleACS omega2018
Multifunctional CdSNPs@ZIF-8: Potential Antibacterial Agent against GFP-Expressing
Article in ACS omega, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
15 citing papers in PubMed, 68 citations in OpenAlex.
- Gas Adsorption-Driven Electronic Modulation in WOSmall (Weinheim an der Bergstrasse, Germany) · 2026Article
- Impact of oxidative stress onmBio · 2026Article
- ZIF-8/graphene composite for photocatalytic degradation under low intensity UV irradiation and antibacterial applications.Scientific reports · 2025Article
- A PDA@ZIF-8-Incorporated PMIA TFN-FO Membrane for Seawater Desalination: Improving Water Flux and Anti-Fouling Performance.Membranes · 2024Article
- Synthesis of Metal-Organic Framework-Based ZIF-8@ZIF-67 Nanocomposites for Antibiotic Decomposition and Antibacterial Activities.ACS omega · 2023Article
- Nanoscale designing of metal organic framework moieties as efficient tools for environmental decontamination.Nanoscale advances · 2023Review
- Synthesis and antibacterial activities of Ag-TiOFrontiers in bioengineering and biotechnology · 2023Article
- Zinc Metal-Organic Framework Growing on the Surface of Fruit Peels and Its Photocatalytic Activity.ACS omega · 2021Article
- Copper@ZIF-8 Core-Shell Nanowires for Reusable Antimicrobial Face Masks.Advanced functional materials · 2021Article
- Strategy for Encapsulation of CdS Quantum Dots into Zeolitic Imidazole Frameworks for Photocatalytic Activity.Nanomaterials (Basel, Switzerland) · 2020Article
- Article
- An NIF-doped ZIF-8 hybrid membrane for continuous antimicrobial treatment.RSC advances · 2020Article
- Cytotoxicity, Antioxidant, Antibacterial, and Photocatalytic Activities of ZnO-CdS Powders.Materials (Basel, Switzerland) · 2020Article
- Article
- Multi-core-shell composite SnOEnvironmental science and pollution research international · 2019Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Multifunctional novel core-shell composites, CdSNPs@ZIF-8, have been synthesized by in situ encapsulation of different amounts of CdSNPs (150, 300, and 500 μL suspension of CdSNPs in methanol) in ZIF-8 at room temperature. These composites have been characterized by powder X-ray diffraction, X-ray photoelectron spectroscopy (XPS), field emission scanning electron microscopy, high-resolution transmission electron microscopy (HRTEM), and diffuse reflectance spectroscopy techniques and Brunauer-Emmett-Teller surface analysis. XPS and HRTEM indicate the encapsulation of CdSNPs within ZIF-8 crystal without disturbing the crystal order of ZIF-8. The average size of embedded CdSNPs (determined by the particle size distribution from HRTEM) is found to be 16.34 nm. CdSNPs@ZIF-8 showed potential to be used as an antibacterial agent against the broad spectrum of bacterial strains such as Gram-positive
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.